4.6 Article

Quantifying regional α-synuclein, amyloid β, and tau accumulation in lewy body dementia

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

APOE genotype regulates pathology and disease progression in synucleinopathy

Albert A. Davis et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Clinical Neurology

Effect of escitalopram on Aβ levels and plaque load in an Alzheimer mouse model

John R. Cirrito et al.

NEUROLOGY (2020)

Article Clinical Neurology

Tau pathology associates with in vivo cortical thinning in Lewy body disorders

Nicola Spotorno et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)

Article Clinical Neurology

Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders

David Coughlin et al.

ANNALS OF NEUROLOGY (2019)

Article Biochemistry & Molecular Biology

Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics

Tritia R. Yamasaki et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Review Clinical Neurology

Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies

Kurt A. Jellinger

JOURNAL OF NEURAL TRANSMISSION (2018)

Article Geriatrics & Gerontology

Correlation between decreased CSF α-synuclein and Aβ1-42 in Parkinson disease

Chandana Buddhala et al.

NEUROBIOLOGY OF AGING (2015)

Article Clinical Neurology

Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease

Chandana Buddhala et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)

Article Clinical Neurology

A quantitative study of α-synuclein pathology in fifteen cases of dementia associated with Parkinson disease

Richard A. Armstrong et al.

JOURNAL OF NEURAL TRANSMISSION (2014)

Article Clinical Neurology

G51D α-Synuclein mutation causes a novel Parkinsonian-pyramidal syndrome

Suzanne Lesage et al.

ANNALS OF NEUROLOGY (2013)

Article Clinical Neurology

Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease

Silke Appel-Cresswell et al.

MOVEMENT DISORDERS (2013)

Editorial Material Clinical Neurology

A NOVEL α-SYNUCLEIN MISSENSE MUTATION IN PARKINSON DISEASE

Christos Proukakis et al.

NEUROLOGY (2013)

Article Clinical Neurology

Neuropathologic substrates of Parkinson disease dementia

David J. Irwin et al.

ANNALS OF NEUROLOGY (2012)

Article Clinical Neurology

Pathologic Accumulation of α-Synuclein and Aβ in Parkinson Disease Patients With Dementia

Paul T. Kotzbauer et al.

ARCHIVES OF NEUROLOGY (2012)

Article Clinical Neurology

CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease

A. Siderowf et al.

NEUROLOGY (2010)

Article Clinical Neurology

Parkinson Disease With Dementia Comparing Patients With and Without Alzheimer Pathology

Marwan N. Sabbagh et al.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2009)

Article Clinical Neurology

Neuroanatomical Substrate of Visuospatial and Visuoperceptual Impairment in Parkinson's Disease

Joana B. Pereira et al.

MOVEMENT DISORDERS (2009)

Article Clinical Neurology

Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease

M. E. Kalaitzakis et al.

PARKINSONISM & RELATED DISORDERS (2009)

Review Clinical Neurology

Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease

Kurt A. Jellinger et al.

ACTA NEUROPATHOLOGICA (2008)

Article Clinical Neurology

Validation of the neuropathologic criteria of the Third Consortium for Dementia with Lewy bodies for prospectively diagnosed cases

Hiroshige Fujishiro et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)

Article Clinical Neurology

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

Mariese A. Hely et al.

MOVEMENT DISORDERS (2008)

Review Clinical Neurology

Clinical diagnostic criteria for dementia associated with Parkinson's disease

Murat Emre et al.

MOVEMENT DISORDERS (2007)

Article Clinical Neurology

Irreversible motor impairment in young addicts - ephedrone, manganism or both?

K. Sikk et al.

ACTA NEUROLOGICA SCANDINAVICA (2007)

Article Geriatrics & Gerontology

Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases

O Pletnikova et al.

NEUROBIOLOGY OF AGING (2005)

Article Clinical Neurology

The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia

JJ Zarranz et al.

ANNALS OF NEUROLOGY (2004)

Review Clinical Neurology

Cognitive dysfunction and dementia in Parkinson's disease

JLW Bosboom et al.

JOURNAL OF NEURAL TRANSMISSION (2004)

Review Cell Biology

Stages in the development of Parkinson's disease-related pathology

H Braak et al.

CELL AND TISSUE RESEARCH (2004)

Article Multidisciplinary Sciences

α-synuclein locus triplication causes Parkinson's disease

AB Singleton et al.

SCIENCE (2003)

Article Clinical Neurology

Fluctuations in attention - PD dementia vs DLB with parkinsonism

CG Ballard et al.

NEUROLOGY (2002)

Review Ophthalmology

Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review

Evita Evangelia Christou et al.

Summary: The retina may serve as a predictive factor for neurodegenerative disorders, with recent use of Optical Coherence Tomography Angiography (OCT-A) in studying macular microcirculation changes in Parkinson's disease (PD). While preliminary evidence suggests OCT-A could be a useful biomarker for cerebral vasculature in PD, further research is needed to confirm its predictive value in clinical practice.

SEMINARS IN OPHTHALMOLOGY